• Elementis plans to increase R&D spending by $6 million, raising it from about 2% to about 3% of sales.
• Lab upgrades will receive $15 million in capital spending over 2026-2028.
• Innovation sales are targeted at 20% of total sales in the medium term, up from 16% in 2025.
• Innovation is expected to generate about one-third of growth, supported by a pipeline that has more than tripled over two years.
• Medium-term targets include mid-single-digit revenue growth, an adjusted operating margin of at least 23% and cash conversion above 90%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elementis plc published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.